Medpace Holdings is a holding company. Through its subsidiaries, Co. is a global provider of clinical research-based drug and medical device development services. Co. provides a suite of services supporting the entire clinical development process from Phase I to Phase IV across a range of therapeutic areas. Co.'s clinical development services include medical department, clinical trial management, data-driven feasibility, study start-up, patient recruitment and retention, clinical monitoring, risk-based monitoring, regulatory affairs, medical writing, biometrics and data sciences, pharmacovigilance, main laboratory, central laboratory, bioanalytical laboratory, clinics and quality assurance.